Tower Research Capital LLC TRC Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Tower Research Capital LLC TRC raised its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 28.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,148 shares of the company’s stock after purchasing an additional 1,808 shares during the quarter. […]
Tower Research Capital LLC TRC raised its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 28.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,148 shares of the company’s stock after purchasing an additional 1,808 shares during the quarter. […]
